Litigation for DILTIAZEM HYDROCHLORIDE
✉ Email this page to a colleague
US Court Litigation for DILTIAZEM HYDROCHLORIDE
Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
---|---|---|---|---|---|---|---|---|
6,162,463 | Takeda Pharmaceutical Co v. Impax Laboratories, Inc. | See Plans and Pricing | 2013-11-18 | Court of Appeals for the Federal Circuit | See Plans and Pricing | |||
6,923,984 | See Plans and Pricing | See Plans and Pricing | 2019-08-02 | 2020-08-11 | 15:15 Antitrust Litigation | District Court, S.D. New York | Plaintiff | See Plans and Pricing |
6,923,984 | CVS Pharmacy, Inc. v. Astrazeneca Pharmaceuticals L.P. | See Plans and Pricing | 2019-10-29 | 2020-08-12 | 15:1 Antitrust Litigation (Monopolizing Trade) | District Court, S.D. New York | See Plans and Pricing | |
6,923,984 | CVS Pharmacy, Inc. v. Astrazeneca Pharmaceuticals L.P. | See Plans and Pricing | 2019-10-29 | 15:1 Antitrust Litigation (Monopolizing Trade) | District Court, S.D. New York | See Plans and Pricing | ||
>Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |